180 Life Sciences Corp. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
180 Life Sciences Corp. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • 180 Life Sciences Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$264K, a 43.7% increase year-over-year.
  • 180 Life Sciences Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.91M, a 45.7% decline from 2022.
  • 180 Life Sciences Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $10.9M, a 57.2% decline from 2021.
  • 180 Life Sciences Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $25.4M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.91M -$4.97M -45.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $10.9M -$14.5M -57.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $25.4M +$34.1M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$8.73M +$97.8M +91.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$107M -$107M -68007% Jan 1, 2019 Dec 31, 2019 10-K 2020-04-07
2018 $157K -$117M -99.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-07
2017 $117M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.